The open-source libraries were created by Salesforce, Nvidia, and Apple with a Swiss group Vulnerabilities in popular AI and ...

Editor's note: This story includes references to suicide. Information about suicide warning signs and resources for people in crisis can be found at the bottom of this story. The family of 19-year-old ...

SEOUL – NewJeans’ label Ador has filed a damages suit worth over 43 billion won (S$38 million) against the K-pop girl group’s former member Danielle, her family member and the agency’s former chief ...

It comes after the latest files showed pics of Epstein following a "possible suicide attempt" THE “Invisible Man” who asked Ghislaine Maxwell for “inappropriate friends” in the latest batch of Jeffrey ...

The Department of Justice (DOJ) on Saturday released more files, documents and photos connected to convicted sex offender Jeffrey Epstein, a day after the deadline for releasing all of the files. The ...

If the Epstein files were meant to deliver closure, they’ve instead reopened old grudges. As the Justice Department’s latest document dump reignited public outrage, former President Bill Clinton found ...

Imagine being able to upload a dense financial statement or a lengthy legal contract and have the key details summarized and organized for you in seconds. Sounds like a dream, right? In the video, ...

The Justice Department released thousands – but not all – of its Jeffrey Epstein files on Dec. 19, an apparent violation of a law that ordered the department to publicize all its investigative ...

Irish renewable energy developer Solar 21 has said it will “vigorously” defend itself against a petition that a group of investors presented to the High Court earlier this week to wind up two of its ...

Samsung has unveiled its groundbreaking Galaxy Z TriFold, a 10-inch foldable smartphone launching in South Korea on December 12, 2025. This innovative device boasts a 6.5-inch cover screen and a ...

On November 25, 2025, Sarepta Therapeutics filed two petitions for inter partes review (“IPR”) challenging Genzyme’s patents relating to the characterization of recombinant adeno-associated virus ...